Live Breaking News & Updates on Disease Puzzle

Stay updated with breaking news from Disease puzzle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscape in Alzheimer's Disease Treatment Options with Leaders and Experts on April 15th, 2021


01.04.2021 - 07:02 Uhr
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscape in Alzheimer s Disease Treatment Options with Leaders and Experts on April 15th, 2021
Vivoryon Therapeutics N.V., NL00150002Q7Despite repeated clinical trial failures in the AD space, a determined group of pharma and biotech companies has not given up on seeking for therapies that address the high unmet medical need in this indication. Vivoryon s interactive session will cover discussions surrounding current hurdles and exciting, novel approaches to the challenging AD space, including the company s clinical phase 2 compound, varoglutamstat, a small molecule inhibitor of glutaminyl cyclase (QC) capable of targeting all three hallmarks of AD: amyloid-beta, tau, and neuroinflammation. ....

Noord Holland , Ulrich Dauer , Halle Saale , Philip Scheltens , Howard Feldman , Frank Weber , Dementia Fund , English Company , Alzheimer Center Amsterdam , Department Of Neurosciences , Distribution Services , Alzheimer Disease Cooperative Study , Us National Institutes On , News Service , Communications Gretchen Schweitzer Valeria Fisher Tel , Disease Puzzle , Professor Philip Scheltens , Managing Partner , Disease Cooperative Study , California San Diego School , Chief Medical Officer , European Alzheimer , Disease Phase , Communications Gretchen Schweitzer , Valeria Fisher Tel , Forward Looking Statementsinformation ,

Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscap


Search jobs
01-Apr-2021
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscape in Alzheimer s Disease Treatment Options with Leaders and Experts on April 15th, 2021
DGAP-News: Vivoryon Therapeutics N.V.
/ Key word(s): Miscellaneous
01.04.2021 / 07:00
The issuer is solely responsible for the content of this announcement.
Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscape in Alzheimer s Disease Treatment Options with Leaders and Experts on April 15
th, 2021
HALLE (SAALE) / MUNICH, GERMANY, 1 April 2021 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (
Vivoryon) announced today that it will host a virtual event covering next steps in Alzheimer s Disease (AD) treatment options with leaders and experts in the field on Thursday, April 15 ....

Ulrich Dauer , Gretchen Schweitzer Valeria Fisher , Philip Scheltens , Howard Feldman , Frank Weber , Dementia Fund , Alzheimer Disease Cooperative Study , Us National Institutes On , Alzheimer Center Amsterdam , Trophic Communications , Department Of Neurosciences , Distribution Services , Host Virtual Event , Current Clinical Landscape , Disease Treatment Options , Euronext Amsterdam , Disease Puzzle , Managing Partner , Disease Cooperative Study , California San Diego School , Chief Medical Officer , European Alzheimer , Disease Phase , Corporate News , Regulatory Announcements , உல்ரிச் அச்சுறுத்தல் ,